Almirall

Patent cliffs & loss of exclusivity

Pharmaceutical company

Company

AngelList URLhttps://angel.co/almirall-pharmaceuticals
Legal NameAlmirall, S.A.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/almirall
Full AddressRonda del General Mitre, 151 08022 Barcelona Spain
LinkedIn URLhttp://www.linkedin.com/company/almirall
Stock SymbolALM
Twitter URLhttps://twitter.com/AlmirallUS

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. ALTABAXRETAPAMULINSmall mol.Feb 2027
  2. SEYSARASARECYCLINE HYDROCHLORIDESmall mol.Feb 2033
  3. SEYSARASARECYCLINE HYDROCHLORIDESmall mol.Feb 2033
  4. SEYSARASARECYCLINE HYDROCHLORIDESmall mol.Feb 2033
  5. ACZONEDAPSONESmall mol.Nov 2033
  6. KLISYRITIRBANIBULINSmall mol.Sep 2038
  7. AVAGETAZAROTENESmall mol.
  8. AZELEXAZELAIC ACIDSmall mol.
  9. TAZORACTAZAROTENESmall mol.
  10. TAZORACTAZAROTENESmall mol.
  11. ACZONEDAPSONESmall mol.
  12. TAZORACTAZAROTENESmall mol.
  13. TAZORACTAZAROTENESmall mol.
  14. VELTINCLINDAMYCIN PHOSPHATE; TRETINOINSmall mol.
  15. SOLAGEMEQUINOL; TRETINOINSmall mol.
  16. CORDRANFLURANDRENOLIDESmall mol.

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Almirall — patent cliffs & loss of exclusivity | CliffBio